What's Happening?
Independent Film Company has secured the North American rights to 'The Plague,' a psychological thriller directed by Charlie Polinger. The film, which stars Joel Edgerton and newcomers Everett Blunck, Kayo Martin, and Kenny Rasmussen, premiered at the Cannes Film Festival, receiving an 11-minute standing ovation and winning an award for best sound creation. 'The Plague' explores the experiences of a socially awkward teen facing bullying at a water polo camp. The film is set for a limited theatrical release on December 24, with a wider release planned for January 2. The acquisition by Independent Film Company, known for arthouse successes like 'Boyhood' and 'The Babadook,' marks a significant step in bringing the film to a broader audience.
AD
Why It's Important?
The acquisition of 'The Plague' by Independent Film Company highlights the growing interest in psychological thrillers and films that delve into complex social issues. The film's exploration of adolescence and bullying resonates with contemporary societal concerns, potentially sparking discussions on these topics. For the U.S. film industry, this acquisition underscores the importance of international film festivals like Cannes in showcasing new talent and innovative storytelling. The film's success could bolster Independent Film Company's reputation as a distributor of critically acclaimed films, potentially influencing future acquisitions and productions.
What's Next?
Following its limited release, 'The Plague' will expand to more theaters, allowing a wider audience to experience the film. The reception of the film in the U.S. market will be closely watched, as it could impact the future projects of director Charlie Polinger and the involved production companies. Additionally, the film's themes may prompt discussions among educators, parents, and policymakers about bullying and adolescent mental health, potentially influencing public discourse and policy.
